Bivision Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel targeted radiopharmaceuticals to address significant unmet medical needs.
As an innovative biopharmaceutical company dedicated to the discovery, development and commercialization of radiopharmaceuticals, Bivision is committed to provide better radiopharmaceuticals to patients and allow them to have a quality of life style.
Patient-oriented, Innovation-driven, Excellence in "precise"
Discovery, development and commercialization of novel radiopharmaceuticals to address unmet medical needs.
